Burgess Michael F.
Insider CIK 1801745 · SYBX Director · TSBX Interim Chief Medical Officer, Director · SWTX Head of Research & Development
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TSBX Turnstone Biologics Corp. | A Award deriv | 2023-10-16 | 2023-10-17 | 11,464 | — | $0 | 11,464 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award deriv | 2023-06-22 | 2023-06-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SWTX SpringWorks Therapeutics, | F Tax w/h | 2022-07-18 | 2022-07-20 | 3,103 | $28.47 | $88.3K | 49,584 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award | 2022-06-30 | 2022-07-05 | 12,185 | — | $0 | 52,687 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award deriv | 2022-06-09 | 2022-06-13 | 27,000 | — | $0 | 27,000 | SEC↗ |
| SWTX SpringWorks Therapeutics, | F Tax w/h | 2022-06-01 | 2022-07-05 | 2,672 | $19.61 | $52.4K | 40,502 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2022-01-06 | 2022-01-10 | 48,852 | — | $0 | 48,852 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award | 2022-01-06 | 2022-01-10 | 15,674 | — | $0 | 43,174 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award deriv | 2021-06-10 | 2021-06-14 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2021-06-01 | 2021-06-01 | 225,000 | — | $0 | 225,000 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award | 2021-06-01 | 2021-06-01 | 27,500 | — | $0 | 27,500 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award deriv | 2020-06-04 | 2020-06-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award deriv | 2020-02-03 | 2020-02-04 | 30,000 | — | $0 | 30,000 | SEC↗ |